India Business News: New Delhi: Singapore-based healthcare-focused PE firm Quadria Capital has announced an investment of $102 million (Rs 850 crore) in NephroPlus, Asia's.
NephroPlus, India s largest dialysis chain, has secured $103 million (₹860 crore) in a Series F funding round led by Quadria Capital. This funding, a mix of fresh capital and a secondary sale, aims to drive expansion plans within India and targeted markets overseas. The primary component of the funding is ₹100 crore. Quadria Capital will become a minority shareholder, valuing NephroPlus at over ₹2,000 crore. Existing investors like Bessemer Venture Partners, International Finance Corporation, and IIFL also participated in the funding round, reducing their stakes.
India Business News: HYDERABAD: Dialysis care provider NephroPlus on Wednesday said it has acquired Philippines-based Renal Therapy Solutions Inc (RTSI), which has six cli.
Asia healthcare-focussed private equity firm Quadria Capital, which has backed names like Maxivision Eye Hospitals, MediBuddy, Nobel Hygiene and Concord Biotech, is now eyeing a ..
Quadria Capital, an Asia-focused private equity fund, is in talks to acquire a significant minority stake in India s largest dialysis chain, NephroPlus, valued at ₹2,000 crore ($250 million). Existing investors, Bessemer Venture Partners and International Finance Corporation, will exit by selling a 30% stake together, while Investcorp is likely to sell a small stake. NephroPlus, founded in 2009, operates 300+ dialysis centres in over 180 cities across four countries.